MBBCH, Faculty of Medicine, Cairo University, 2001 MSc Diagnostic Radiology, Faculty of Medicine, Cairo University, 2007 Scholar, Interventional Radiology, Stanford University, CA, USA, 2009 Doctoral degree, Faculty of Medicine, Cairo University, 2015
Interventional radiologist specializing in cancer treatment and portal hypertension management
Experience
—
Languages
Arabic, English
Location
Dubai Healthcare City, Dubai
Sees
adults
Dr. Mohamed Abdelmaksoud is an assistant professor of interventional radiology and head of the Interventional Radiology Unit at Theodor Bilharz Research Institute in Egypt. He trained at Cairo University's Faculty of Medicine and completed an interventional radiology scholarship at Stanford University in California. He is a consultant interventional radiologist with Dubai Health Authority and a visiting scholar at Stanford's Interventional Radiology Department.
Dr. Abdelmaksoud specializes in minimally invasive image-guided procedures to treat liver cancer and other conditions. His core expertise includes radioactive microsphere treatment (a form of targeted radiation therapy for liver tumors), chemoembolization (injecting chemotherapy directly into tumors), and management of portal hypertension—a serious liver complication—using advanced catheter techniques. He also performs biliary drainage and stenting, uterine fibroid embolization, treatment of blood clots and varicose veins, and CT-guided interventions. He opened a specialized unit for advanced interventional radiology in Egypt in 2011 and has supervised Y90 radioembolization cases across Europe, Asia, and Africa as an official proctor for SIRTEX (the leading company in this field).
Dr. Abdelmaksoud is an active researcher and educator, publishing widely on interventional oncology and serving as a reviewer for major international journals including the Journal of Vascular and Interventional Radiology. He leads multiple international clinical trials, particularly focused on liver cancer treatment. He is a strong fit if you need advanced minimally invasive cancer treatment, complex liver interventions, or image-guided catheter procedures performed by a highly experienced and internationally recognized specialist.
Special interests: hepatocellular carcinoma treatment, Y90 radioembolization, chemoembolization, image-guided procedures.
Extracted from the doctor's hospital profile — patient-friendly terms
MBBCH (Bachelor of Medicine, Bachelor of Surgery)
Faculty of Medicine, Cairo University, Egypt · 2001
MSc Diagnostic Radiology
Faculty of Medicine, Cairo University, Egypt · 2007
Scholar, Interventional Radiology
Interventional Radiology Department, Stanford University, United States · 2009
Doctoral degree
Faculty of Medicine, Cairo University, Egypt · 2015
Head of Interventional Radiology Unit and Assistant Professor
Theodor Bilharz Research Institute, Egypt · 2011-present
Radiology Resident
Theodor Bilharz Research Institute, Egypt
Interventional Radiology Scholar
Stanford University Interventional Radiology Department, United States · 2009
Consultant Interventional Radiologist
Dubai Health Authority, United Arab Emirates
Consultations are available in Arabic, English.
Mediclinic — Mediclinic City Hospital Consultant Interventional Radiology In department Interventional Radiology, Dubai Healthcare City, Dubai.
This doctor primarily sees adults.
Commonly treated: Biliary Obstruction, Deep Vein Thrombosis, Kidney Blockage, Liver Cancer, Portal Hypertension, Uterine Fibroids, Varicose Veins.
Profile compiled from Mediclinic's public website (see original profile via the booking link). Data is informational, not medical advice.
Mediclinic City Hospital
Bldg 37 - 26th St - Umm Hurair 2 - Dubai Healthcare City - Dubai
+971 800 1999Mediclinic City Hospital: 3.8★ · 2,416 Google reviews — Google rating for the clinic, not this doctor.
No patient reviews yet — be the first.
Visited Dr. Mohamed Abdelmaksoud? Your experience helps others choose with confidence.
Write the first reviewReviews are written by signed-in users who attest to a visit, screened before publication, and labeled “Patient-reported” until visit verification launches. They are opinions, not medical advice.